Kazazian Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Kazazian Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$731K	Hold	14,424	–	–	0.99%	26
2019 Q2	$654K	Sell	14,424 -1,323	-8%	-$61.6K	0.78%	32
2019 Q1	$751K	Sell	15,747 -3,500	-18%	-$174K	1.04%	24
2018 Q4	$1M	Sell	19,247 -9,578	-33%	-$515K	1.35%	20
2018 Q3	$1.79M	Sell	28,825 -5,010	-15%	-$297K	1.68%	14
2018 Q2	$1.87M	Buy	33,835 +15,114	+81%	+$816K	1.72%	13
2018 Q1	$1.18M	Sell	18,721 -1,171	-6%	-$75.3K	1.24%	24
2017 Q4	$1.22M	Sell	19,892 -2,452	-11%	-$153K	1.25%	21
2017 Q3	$1.42M	Buy	22,344 +7,137	+47%	+$417K	1.74%	17
2017 Q2	$847K	Buy	15,207 +4,177	+38%	+$227K	1.28%	20
2017 Q1	$600K	Buy	+11,030	New	+$605K	0.83%	20

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kazazian Asset Management's BMY Position: Q3 2019 in Review

Kazazian Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q3 2019 at 14,424 shares worth $731K. The position accounts for 0.99% of the portfolio, ranked #26.

Kazazian Asset Management first reported a position in BMY in Q1 2017 and has held it in 11 quarters since. The position peaked at $1.87M in Q2 2018. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

Kazazian Asset Management held 14,424 shares of Bristol-Myers Squibb worth $731K as of Q3 2019.
Kazazian Asset Management left its Bristol-Myers Squibb share count unchanged in Q3 2019.
Bristol-Myers Squibb made up 0.99% of Kazazian Asset Management's portfolio in Q3 2019, its #26 holding.
Kazazian Asset Management first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 11 quarters since.
Kazazian Asset Management's Bristol-Myers Squibb position peaked at $1.87M in Q2 2018.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Kazazian Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.